Nitric oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications

用于泌尿导管应用的一氧化氮释放超光滑抗菌表面

• 批准号: 10759903
• 负责人: Ronald J. Shebuski
• 金额: $ 33.74万
• 依托单位: NYTRICX INC.
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-15 至 2024-07-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10759903
• 关键词: Adhesions; Affect; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Therapy; Bacteremia; Bacteria; Bacterial Adhesion; Bacteriuria; Biocompatible Materials; Biological; Businesses; Cannulas; Catheterization; Catheters; Cell Line; Cell Survival; Chronic; Clinical; Data; Development; Devices; Disinfection; Elderly; Ensure; Escherichia coli; Formulation; Fortune; Goals; Growth; Guidelines; Health Care Costs; Hospitalization; Hospitals; Human; In Vitro; Industrialization; Indwelling Catheter; Infection; Inflammation; Infusion procedures; Kidney; Lead; Length of Stay; Letters; Liquid substance; Malignant neoplasm of urinary bladder; Mammalian Cell; Marketing; Mechanics; Medical; Medical Device; Methods; Microbial Biofilms; N-acetylpenicillamine; Nitric Oxide; Nitric Oxide Donors; Nursing Homes; Operative Surgical Procedures; Patients; Peritoneal Dialysis; Phase; Polymers; Population; Probability; Procedures; Property; Proteins; Proteus mirabilis; Pyelonephritis; Risk; Silicone Oils; Small Business Innovation Research Grant; Surface; Surface Properties; Technology; Tube; United States National Institutes of Health; Urinary Catheterization; Urinary Incontinence; acute pyelonephritis; aging population; antimicrobial; catheter associated UTI; commercialization; cooking; cytotoxic; endotracheal; experience; healthcare-associated infections; infection risk; insight; interest; mechanical properties; medical complication; prevent; response; urinary; urologic

Abstract Urinary catheters are one of the most widely used medical devices in a hospital setting and are expected to only increase in growth due to the aging population. Out of all the various biomedical devices that are frequently used in a clinical setting, urinary catheters are associated with the largest portion of medical complications related to infection. Catheter associated urinary tract infections (CAUTIs) account for nearly 40% of all healthcare associated infections (HAIs) and can lead to extended hospital stays for patients which in turn leads to higher healthcare costs. To overcome this risk of infection, a catheter surface that is able to prevent bacterial adhesion and biofilm formation while simultaneously eliminating planktonic bacteria present in the vicinity is highly desirable. However, no long-term catheter solution has been able to accomplish this goal. Nytricx, Inc. has developed proprietary methods and know-how developing anti-infective nitric oxide (NO) releasing interfaces capable of effectively eliminating a wide variety of bacterial strains while being able to elicit no cytotoxic response from mammalian cell lines. Nytricx, Inc. has also demonstrated that the liquid-infusion of silicone oil to create a super slippery surface is able to prevent the adhesion of proteins and bacteria and thus eliminate biofilms. A synergistic antimicrobial response is achieved by combining liquid-infused strategy and NO releasing polymers (LINORel). The overall objective of this Phase I SBIR application is to create a long-term highly antimicrobial urinary catheter through a combination of impregnating Foley catheters with a NO donor, S-nitroso-N- acetylpenicillamine (SNAP), with a liquid-infused silicone oil interface and to evaluate commercialization feasibility in terms of mechanical and biological properties.

摘要